Company · CIK 0001095981 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
PLUS THERAPEUTICS, INC. · CNSY
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Ronald Asbury AndrewsDirector | 922 | — | — | 922 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Kyle GuseDirector | 922 | — | — | 922 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | An van Es-JohanssonDirector | 922 | — | — | 922 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Marc H HedrickChief Executive Officer, Director | 16,439 | — | — | 44,483 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Howard ClowesDirector | 922 | — | — | 1,981 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Richard J HawkinsDirector | 922 | — | — | 1,529 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Andrew John Hugh MacIntyre SimsChief Financial Officer | 2,985 | — | — | 9,941 | — | |
| Feb 14, 2018 SForm 4 → | Feb 15, 4:05 pm EST | PostFinance AG10% Owner | 473,831 | $0.3398 | $161,008 | 4,543,086 | −9.44% | plan? |
| Feb 12, 2018 SForm 4 → | Feb 14, 4:19 pm EST | PostFinance AG10% Owner | 286,982 | $0.3135 | $89,976 | 5,016,917 | −5.41% | plan? |
| Feb 8, 2018 SForm 4 → | Feb 12, 4:07 pm EST | PostFinance AG10% Owner | 236,155 | $0.343 | $81,001 | 5,303,899 | −4.26% | plan? |
| Jan 9, 2018 SForm 4 → | Jan 11, 12:08 pm EST | Swissquote Bank SA10% Owner | 188,426 | $0.3665 | $69,055 | 5,328,229 | −3.42% | plan? |
| Aug 10, 2016 PForm 4 → | Aug 11, 4:51 pm EDT | John David HarrisVP and GM Cell Therapy | 2,500 | $2.03 | $5,075 | 7,000 | +55.6% | plan? |
| Jun 15, 2016 XForm 4 → | Jun 16, 4:04 pm EDT | Gary A LyonsDirector | 1,900 | — | — | 4,358 | — | plan? |
| Jun 15, 2016 XForm 4 → | Jun 15, 7:09 pm EDT | David RickeyDirector | 22,000 | — | — | 71,226 | — | plan? |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:58 pm EDT | Richard J HawkinsDirector | 3,356 | — | — | 8,435 | — | plan? |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:56 pm EDT | Steven KestenExec VP and Chief MO | 200 | — | — | 3,481 | — | plan? |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:53 pm EDT | Tiago GiraoVP & Chief Financial Officer | 5,667 | — | — | 14,084 | — | plan? |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:52 pm EDT | John David HarrisVP and GM Cell Therapy | 2,500 | — | — | 4,500 | — | plan? |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:50 pm EDT | Jeremy B. HaydenGeneral Counsel & VP of BD | 1,896 | — | — | 3,643 | — | plan? |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:48 pm EDT | Marc H HedrickPresident and CEO, Director | 41,305 | — | — | 44,292 | — | plan? |
| Jun 14, 2016 PForm 4 → | Jun 15, 7:03 pm EDT | David RickeyDirector | 5,000 | $2.10 | $10,500 | 55,226 | +9.96% | plan? |
| Jun 14, 2016 PForm 4 → | Jun 15, 7:00 pm EDT | Gail K NaughtonDirector | 1,000 | $2.10 | $2,100 | 2,400 | +71.4% | plan? |
| May 13, 2016 PForm 4 → | May 16, 4:31 pm EDT | John David HarrisVP and GM Cell Therapy | 2,000 | $2.71 | $5,420 | 2,000 | — | plan? |
| Mar 9, 2016 PForm 4 → | Mar 9, 5:55 pm EST | David RickeyDirector | 150,000 | $0.1886 | $28,290 | 753,385 | +24.9% | plan? |
| Jan 28, 2016 AForm 4/A → | Feb 5, 4:35 pm EST | Tiago GiraoVP & Chief Financial Officer | 35,250 | — | — | 126,250 | — | plan? |
| Jan 28, 2016 AForm 4 → | Feb 1, 7:11 pm EST | Steven KestenExec VP and Chief MO | 47,000 | — | — | 49,201 | — | plan? |
| Jan 28, 2016 AForm 4 → | Feb 1, 7:10 pm EST | Tiago GiraoVP & Chief Financial Officer | 35,250 | — | — | 123,250 | — | plan? amended |
| Jan 28, 2016 AForm 4 → | Feb 1, 7:09 pm EST | Marc H HedrickPresident and CEO, Director | 70,500 | — | — | 575,111 | — | plan? |
| Sep 3, 2015 PForm 4 → | Sep 8, 4:19 pm EDT | Tommy G ThompsonDirector | 25,449 | $0.3745 | $9,531 | 83,600 | +43.8% | plan? |
| Sep 2, 2015 PForm 4 → | Sep 3, 6:00 am EDT | Jeremy B. HaydenGeneral Counsel & VP of BD | 8,200 | $0.355 | $2,911 | 26,200 | +45.6% | plan? |
| Aug 28, 2015 PForm 4 → | Aug 31, 4:11 pm EDT | David RickeyDirector | 56,000 | $0.3148 | $17,629 | 653,385 | +9.37% | plan? |
| Aug 27, 2015 PForm 4 → | Aug 31, 8:27 am EDT | Marc H HedrickPresident and CEO, Director | 11,200 | $0.3057 | $3,424 | 44,800 | +33.3% | plan? |
| Aug 26, 2015 PForm 4 → | Aug 28, 7:12 am EDT | David RickeyDirector | 75,000 | $0.3085 | $23,135 | 632,385 | +13.5% | plan? |
| Aug 21, 2015 PForm 4 → | Aug 25, 5:11 pm EDT | Marc H HedrickPresident and CEO, Director | 5,000 | $0.35 | $1,750 | 33,600 | +17.5% | plan? |
| Aug 21, 2015 PForm 4 → | Aug 24, 4:05 pm EDT | David RickeyDirector | 50,000 | $0.375 | $18,750 | 557,385 | +9.85% | plan? |
| Aug 21, 2015 PForm 4 → | Aug 24, 4:03 pm EDT | Marc H HedrickPresident and CEO, Director | 5,000 | $0.38 | $1,900 | 28,600 | +21.2% | plan? |
| Aug 20, 2015 PForm 4 → | Aug 21, 4:06 pm EDT | Marc H HedrickPresident and CEO, Director | 10,000 | $0.40 | $4,000 | 23,600 | +73.5% | plan? |
| Aug 19, 2015 PForm 4 → | Aug 21, 4:06 pm EDT | Jeremy B. HaydenGeneral Counsel & VP of BD | 18,000 | $0.392 | $7,056 | 18,000 | — | plan? |
| Aug 19, 2015 PForm 4 → | Aug 20, 4:06 pm EDT | David RickeyDirector | 48,600 | $0.3934 | $19,119 | 507,385 | +10.6% | plan? |
| Aug 19, 2015 PForm 4 → | Aug 20, 4:05 pm EDT | Steven KestenExec VP and Chief MO | 6,000 | $0.3871 | $2,323 | 6,000 | — | plan? |
| Aug 18, 2015 PForm 4 → | Aug 20, 4:03 pm EDT | Marc H HedrickPresident and CEO, Director | 10,000 | $0.3949 | $3,949 | 13,600 | +278% | plan? |
| Aug 18, 2015 PForm 4 → | Aug 19, 4:16 pm EDT | David RickeyDirector | 51,400 | $0.393 | $20,200 | 458,785 | +12.6% | plan? |
| Aug 18, 2015 PForm 4 → | Aug 19, 4:12 pm EDT | Tiago GiraoVP & Chief Financial Officer | 25,000 | $0.39 | $9,750 | 88,000 | +39.7% | plan? |
| May 8, 2015 AForm 4 → | May 18, 4:56 pm EDT | Paul W HawranDirector | 19,424 | — | — | 19,424 | — | plan? late |
| May 8, 2015 AForm 4 → | May 18, 4:54 pm EDT | Gary A LyonsDirector | 12,440 | — | — | 12,440 | — | plan? late |
| May 8, 2015 AForm 4 → | May 14, 5:48 pm EDT | Tommy G ThompsonDirector | 42,785 | — | — | 42,785 | — | plan? late |
| May 8, 2015 AForm 4 → | May 14, 5:46 pm EDT | Richard J HawkinsDirector | 34,228 | — | — | 34,228 | — | plan? late |
| Apr 6, 2015 SForm 4 → | Apr 20, 3:27 pm EDT | Kian Thiam Lim10% Owner | 600,000 | $1.37 | $822,540 | 7,400,000 | −7.50% | plan? late |
| Mar 11, 2014 GForm 4 → | Feb 3, 2015, 7:25 pm EST | Marc H HedrickPresident & CEO, Director | 3,000 | — | — | 3,600 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Ronald Asbury AndrewsDirector | 922 | — | — | 2,764 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Kyle GuseDirector | 922 | — | — | 2,764 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | An van Es-JohanssonDirector | 922 | — | — | 2,764 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Marc H HedrickChief Executive Officer, Director | 16,439 | — | — | 153,598 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Howard ClowesDirector | 922 | — | — | 2,764 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Richard J HawkinsDirector | 922 | — | — | 2,764 | — | |
| Jul 1, 2026 MForm 4 → | Jul 1, 4:30 pm EDT | Andrew John Hugh MacIntyre SimsChief Financial Officer | 2,985 | — | — | 27,070 | — | |
| Jul 25, 2018 XForm 4 → | Jul 27, 4:33 pm EDT | Richard J HawkinsDirector | 10,520 | — | — | 10,500 | — | |
| Jul 25, 2018 XForm 4 → | Jul 27, 4:32 pm EDT | Marc H HedrickPresident and CEO | 36,820 | — | — | 36,750 | — | |
| Jul 25, 2018 XForm 4 → | Jul 27, 4:31 pm EDT | Tiago GiraoVP & Chief Financial Officer | 1,052 | — | — | 1,050 | — | |
| Nov 28, 2017 XForm 4 → | Feb 9, 2018, 4:54 pm EST | Gary A LyonsDirector | 1,802 | — | — | 1,800 | — | late |
| Nov 28, 2017 XForm 4 → | Nov 29, 5:40 pm EST | David RickeyDirector | 10,812 | — | — | 10,800 | — | |
| Nov 28, 2017 XForm 4 → | Nov 29, 5:39 pm EST | Gail K NaughtonDirector | 1,802 | — | — | 1,800 | — | |
| Nov 28, 2017 XForm 4 → | Nov 29, 5:36 pm EST | Marc H HedrickPresident and CEO, Director | 16,218 | — | — | 16,200 | — | |
| Nov 28, 2017 XForm 4 → | Nov 29, 5:35 pm EST | Richard J HawkinsDirector | 5,406 | — | — | 5,400 | — | |
| Nov 28, 2017 XForm 4 → | Nov 29, 5:34 pm EST | John David HarrisVP and GM Cell Therapy | 1,802 | — | — | 1,800 | — | |
| Nov 28, 2017 XForm 4 → | Nov 29, 5:33 pm EST | Tiago GiraoVP & Chief Financial Officer | 1,802 | — | — | 1,800 | — | |
| May 22, 2017 AForm 4 → | May 24, 4:35 pm EDT | Anthony Gregg LapointeDirector | 50,000 | — | — | 50,000 | — | |
| Mar 8, 2017 AForm 4/A → | Mar 17, 5:10 pm EDT | Mark MarinoChief Medical Officer | 31,100 | — | — | 31,100 | — | |
| Mar 8, 2017 AForm 4/A → | Mar 17, 5:10 pm EDT | Marc H HedrickPresident and CEO, Director | 96,350 | — | — | 96,350 | — | |
| Mar 8, 2017 AForm 4/A → | Mar 17, 5:08 pm EDT | Jeremy B. HaydenGeneral Counsel & VP of BD | 31,100 | — | — | 31,100 | — | |
| Mar 8, 2017 AForm 4/A → | Mar 17, 5:07 pm EDT | John David HarrisVP and GM Cell Therapy | 31,100 | — | — | 31,100 | — | |
| Mar 8, 2017 AForm 4/A → | Mar 17, 5:06 pm EDT | Tiago GiraoVP & Chief Financial Officer | 31,100 | — | — | 31,100 | — | |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:58 pm EST | Mark MarinoChief Medical Officer | 42,000 | — | — | 42,000 | — | amended |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:57 pm EST | Marc H HedrickPresident and CEO, Director | 130,200 | — | — | 130,200 | — | amended |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:56 pm EST | Jeremy B. HaydenGeneral Counsel & VP of BD | 42,000 | — | — | 42,000 | — | amended |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:56 pm EST | John David HarrisVP and GM Cell Therapy | 42,000 | — | — | 42,000 | — | amended |
| Mar 8, 2017 AForm 4 → | Mar 10, 5:55 pm EST | Tiago GiraoVP & Chief Financial Officer | 42,000 | — | — | 42,000 | — | amended |
| Jan 26, 2017 AForm 4 → | Jan 27, 5:49 pm EST | Richard J HawkinsDirector | 25,000 | — | — | 25,000 | — | |
| Jan 26, 2017 AForm 4 → | Jan 27, 5:49 pm EST | Gary A LyonsDirector | 25,000 | — | — | 25,000 | — | |
| Jan 26, 2017 AForm 4 → | Jan 27, 5:48 pm EST | Paul W HawranDirector | 25,000 | — | — | 25,000 | — | |
| Jan 26, 2017 AForm 4 → | Jan 27, 5:48 pm EST | Gail K NaughtonDirector | 25,000 | — | — | 25,000 | — | |
| Jan 26, 2017 AForm 4 → | Jan 27, 5:47 pm EST | David RickeyDirector | 25,000 | — | — | 25,000 | — | |
| Jan 26, 2017 AForm 4 → | Jan 27, 5:46 pm EST | Ron MartellDirector | 50,000 | — | — | 50,000 | — | |
| Jun 15, 2016 XForm 4 → | Jun 16, 4:04 pm EDT | Gary A LyonsDirector | 2,850 | — | — | 950 | — | |
| Jun 15, 2016 XForm 4 → | Jun 15, 7:09 pm EDT | David RickeyDirector | 33,000 | — | — | 8,000 | — | |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:58 pm EDT | Richard J HawkinsDirector | 5,034 | — | — | 1,678 | — | |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:56 pm EDT | Steven KestenExec VP and Chief MO | 300 | — | — | 100 | — | |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:53 pm EDT | Tiago GiraoVP & Chief Financial Officer | 8,500 | — | — | 2,833 | — | |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:52 pm EDT | John David HarrisVP and GM Cell Therapy | 3,750 | — | — | 1,250 | — | |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:50 pm EDT | Jeremy B. HaydenGeneral Counsel & VP of BD | 2,844 | — | — | 948 | — | |
| Jun 15, 2016 XForm 4 → | Jun 15, 6:48 pm EDT | Marc H HedrickPresident and CEO, Director | 61,957 | — | — | 20,652 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:57 pm EST | Paul W HawranDirector | 53,820 | — | — | 245,950 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:57 pm EST | Richard J HawkinsDirector | 53,820 | — | — | 220,950 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:56 pm EST | David RickeyDirector | 53,820 | — | — | 245,950 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:55 pm EST | Tommy G ThompsonDirector | 53,820 | — | — | 136,950 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:55 pm EST | Gail K NaughtonDirector | 53,820 | — | — | 99,820 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:54 pm EST | Gary A LyonsDirector | 53,820 | — | — | 99,820 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:54 pm EST | Jeremy B. HaydenGeneral Counsel & VP of BD | 255,645 | — | — | 455,645 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:48 pm EST | Tiago GiraoVP & Chief Financial Officer | 349,830 | — | — | 619,830 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:47 pm EST | John David HarrisVP and GM Cell Therapy | 349,830 | — | — | 684,830 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:46 pm EST | Steven KestenExec VP and Chief MO | 699,660 | — | — | 1,240,660 | — | |
| Jan 4, 2016 AForm 4 → | Jan 4, 5:45 pm EST | Marc H HedrickPresident and CEO, Director | 834,210 | — | — | 2,269,210 | — | |
| Nov 11, 2015 AForm 4 → | Nov 13, 5:07 pm EST | John David HarrisVP and GM Cell Therapy | 335,000 | — | — | 335,000 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 4:46 pm EDT | Jeremy B. HaydenGeneral Counsel & VP of BD | 200,000 | — | — | 200,000 | — | |
| Feb 13, 2015 AForm 4 → | Feb 25, 5:59 pm EST | Tommy G ThompsonDirector | 25,000 | — | — | 83,130 | — | late |
| Feb 13, 2015 AForm 4 → | Feb 13, 6:39 pm EST | Gary A LyonsDirector | 25,000 | — | — | 46,000 | — | |
| Feb 13, 2015 AForm 4 → | Feb 13, 6:37 pm EST | Gail K NaughtonDirector | 25,000 | — | — | 46,000 | — | |
| Feb 13, 2015 AForm 4 → | Feb 13, 6:35 pm EST | Paul W HawranDirector | 25,000 | — | — | 242,130 | — | |
| Feb 13, 2015 AForm 4 → | Feb 13, 6:34 pm EST | Richard J HawkinsDirector | 25,000 | — | — | 167,130 | — | |
| Feb 13, 2015 AForm 4 → | Feb 13, 6:33 pm EST | David RickeyDirector | 25,000 | — | — | 192,130 | — | |
| Jan 30, 2015 AForm 4 → | Feb 3, 7:30 pm EST | John TownsendController | 10,000 | — | — | 138,205 | — | |
| Jan 30, 2015 AForm 4 → | Feb 3, 7:29 pm EST | Norio Seijiro ShirahamaPresident - Asia Pacific | 80,000 | — | — | 832,500 | — | |
| Jan 30, 2015 AForm 4 → | Feb 3, 7:28 pm EST | Tiago GiraoVP & Chief Financial Officer | 120,000 | — | — | 270,000 | — | |
| Jan 30, 2015 AForm 4 → | Feb 3, 7:25 pm EST | Marc H HedrickPresident & CEO, Director | 240,000 | — | — | 1,505,000 | — |